Fig. 2.
Compared dose per day per patient for extended-spectrum cephalosporins (a), oxacephems (b) and vancomycin (c) using among HAP-CDI and HAP-non-CDI group patients
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.